Balyasny Asset Management
SRGA

Balyasny Asset Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Balyasny Asset Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,179
Closed -$235K – 1350
2016
Q2 		$235K Buy
2,179
+1,302
+148% +$152K ﹤0.01% 982
2016
Q1 		$105K Sell
877
-1,586
-64% -$167K ﹤0.01% 1198
2015
Q4 		$293K Buy
2,463
+541
+28% +$69.8K ﹤0.01% 976
2015
Q3 		$327K Buy
1,922
+935
+95% +$179K ﹤0.01% 897
2015
Q2 		$191K Buy
+987
New +$183K ﹤0.01% 1021

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
GCP
Glen Capital Partners Waltham, Massachusetts $68.9M AUM 21.81% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HC
Hillman Company Pittsburgh, Pennsylvania $257M AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Balyasny Asset Management's SRGA Position: Q3 2016 in Review

Balyasny Asset Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2016, closing a stake of 2,179 shares — an estimated $235K sold.

Balyasny Asset Management first reported a position in SRGA in Q2 2015 and held it in 5 quarters. The position peaked at $327K in Q3 2015. 110 funds tracked by Wall St. Rank hold SRGA as of Q3 2016.

  • Balyasny Asset Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Balyasny Asset Management sold 2,179 Surgalign Holdings, Inc. Common Stock shares in Q3 2016, an estimated $235K.
  • Balyasny Asset Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2015 and held it in 5 quarters.
  • Balyasny Asset Management's Surgalign Holdings, Inc. Common Stock position peaked at $327K in Q3 2015.
  • 110 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2016.

Based on Balyasny Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.